Tiziana Life Sciences announced initiation of a Phase Ib clinical trial to evaluate orally administered enteric-coated capsules of foralumab in patients with mild-to-moderate Crohn’s Disease.
[Tiziana Life Sciences Ltd.]
Sorry, but the selected Zotpress account can't be found.